Study Assessing the Safety and Therapeutic Effect of Buprenorphine in MDD Patients
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to assess the therapeutic effect of Buprenorphine in
MDD population.
The secondary objectives of this study are to assess the therapeutic effect, the feasibility
and safety of buprenorphine in a MDD population.